Protalix Biotherapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $15,658 | $10,113 | $18,218 | $17,959 |
Gross Profit | 9,788 | 1,933 | 14,332 | 9,584 |
EBITDA | 1,804 | -3,380 | 7,656 | 4,471 |
EBIT | 1,444 | -3,726 | 7,322 | 4,142 |
Net Income | 164 | -3,619 | 6,494 | 3,236 |
Net Change In Cash | 15,658 | 10,113 | 18,218 | 17,959 |
Free Cash Flow | -5,664 | -5,364 | 3,566 | 4,018 |
Cash | 17,895 | 19,458 | 19,760 | 27,409 |
Basic Shares | 81,271 | 76,612 | 81,057 | 81,217 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $53,399 | $65,494 | $47,638 | $38,350 |
Gross Profit | 29,080 | 42,512 | 28,046 | 22,001 |
EBITDA | 6,520 | 12,937 | -10,782 | -18,943 |
EBIT | 5,216 | 11,746 | -11,868 | -20,061 |
Net Income | 2,932 | 8,312 | -14,927 | -27,582 |
Net Change In Cash | 53,399 | 65,494 | 47,638 | 38,350 |
Free Cash Flow | 7,392 | -2,467 | -25,628 | -11,744 |
Cash | 19,760 | 23,634 | 17,111 | 38,985 |
Basic Shares | 81,057 | 82,424 | 48,472 | 44,140 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.04 |
2025-03-31 | -$0.05 |
2024-12-31 | $0.09 |
